Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 9Rectal Neoplasms 4Stomach Neoplasms 3Liver Neoplasms 3Colorectal Neoplasms 3Carcinoma, Hepatocellular 3Neoplasm Metastasis 2Thrombosis 1Pancreatic Intraductal Neoplasms 1Pancreatic Adenocarcinoma 1Ovarian Neoplasms 1Melanoma 1Gallbladder Neoplasms 1Esophageal Neoplasms 1Colonic Neoplasms 1Carcinoma, Ovarian Epithelial 1Breast Neoplasms 1Bites and Stings 1Bile Duct Neoplasms 1

Interventions

Gemcitabine 13Albumin-Bound Paclitaxel 8Taxes 6130-nm albumin-bound paclitaxel 6Fluorouracil 5Oxaliplatin 4dehydroftorafur 3Radiotherapy, Intensity-Modulated 3Radiotherapy 3Leucovorin 3Irinotecan 3Losartan 2Cisplatin 2tocilizumab 1selicrelumab 1niraparib 1irinotecan sucrosofate 1indusatumab 1folfirinox 1durvalumab 1cobimetinib 1atezolizumab 1X-Rays 1Tiragolumab 1Surgical Procedures, Operative 1Standard of Care 1Specimen Handling 1S 1 (combination) 1Resistance Training 1Radiotherapy, Image-Guided 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pancreatic Adenocarcinoma × Radiotherapy, Conformal × Gastrointestinal × Clear all
NCT00288093 2017-08-18

3-AP and Radiation Therapy in Treating Patients With Stage III Pancreatic Cancer That Cannot Be Removed By Surgery

National Cancer Institute (NCI)

Phase 1 Completed
30 enrolled
Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡